Camber Capital Management »

Genmab A/s -sp shares owned by Camber Capital Management

Quarter-by-quarter ownership of Genmab A/s -sp (GMAB) shares owned by Camber Capital Management from 13F filings

Historical chart of Camber Capital Management investment in Genmab A/s -sp

Tip: Access up to 7 years of quarterly data

All positions including Genmab A/s -sp held by Camber Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Genmab A/s -sp by Camber Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.5M 50k 29.92

More positions owned by Camber Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Zimmer Holdings (ZBH)
Universal Hlth Svcs CL B (UHS)
Baxter International (BAX)
Tenet Healthcare Corp Com New (THC)
Viatris (VTRS)
Walgreen Boots Alliance (WBA)
Myriad Genetics (MYGN)
Medtronic SHS (MDT)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Globus Med Cl A (GMED)
Ptc Therapeutics I (PTCT)
Select Medical Holdings Corporation (SEM)
Brookdale Senior Living (BKD)
GSK Sponsored Adr (GSK)

View all positions for Camber Capital Management

Top funds holding Genmab A/s -sp

Alliancebernstein
BlackRock
BlackRock
Capital Research and Management Company - Division 3
Harding Loevner
Renaissance Technologies
First Trust Advisors
Citadel Advisors
Bank of America Corporation
Envestnet Asset Management
Morgan Stanley
Goldman Sachs Group
Royal Bank of Canada
Two Sigma Investments
Wells Fargo & Company

View all funds holding Genmab A/s -sp